News - Spiriva

Filter

Current filters:

Spiriva

Popular Filters

Pfizer revenues down as patent losses hit sales

Pfizer revenues down as patent losses hit sales

29-10-2013

Global pharma giant Pfizer has said worldwide sales fell 2% to $12.6 billion, hurt by generic competition,…

AriceptEliquisEnbrelFinancialLipitorNorth AmericaPfizerPharmaceuticalRebifSpiriva

COPD trial shows comparable efficacy in Boehringer's Spiriva Respimat and HandiHaler

09-09-2013

One of largest chronic obstructive pulmonary disease (COPD) trials conducted to date confirms comparable…

Boehringer IngelheimEuropePharmaceuticalResearchRespiratory and PulmonarySpiriva

Boehringer Ingelheim presents positive efficacy data for tiotropium in asthma patients

25-02-2013

German family-owned drug major Boehringer Ingelheim presented a new subset of data from the Phase III…

Boehringer IngelheimPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

New LABA/LAMA drugs set to fracture COPD market

10-10-2012

The drug market for chronic obstructive pulmonary disease (COPD) therapies will become more fractured…

AdvairBoehringer IngelheimGlaxoSmithKlineGlobalMarkets & MarketingPfizerPharmaceuticalRespiratory and PulmonarySpiriva

Boehringer reveals new data on olodaterol and tiotropium combo at ERS

04-09-2012

German family-owned drug major Boehringer Ingelheim for the first time presented data from a Phase II…

Boehringer IngelheimolodaterolPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

Boehringer's Spiriva has advantages for patients with COPD, says IQWiG

29-08-2012

In order to widen the narrowed airways in patients with chronic obstructive pulmonary disease (COPD),…

Boehringer IngelheimEuropePharmaceuticalRegulationRespiratory and PulmonarySpiriva

Back to top